![]() |
市場調查報告書
商品編碼
1800893
2025 年至 2033 年電生理設備市場報告(依產品、適應症(心房顫動、室上性心動過速、房室結折返性心動過速、沃爾夫-帕金森-懷特症候群、心動過緩等)、最終用戶和地區分類Electrophysiology Devices Market Report by Product, Indication (Atrial Fibrillation, Supraventricular Tachycardia, Atrioventricular Nodal Re-entry Tachycardia, Wolff-Parkinson-White Syndrome, Bradycardia, and Other), End User, and Region 2025-2033 |
2024年,全球電生理設備市場規模達67億美元。展望未來, IMARC Group預計到2033年,市場規模將達到129億美元,2025-2033年期間的複合年成長率(CAGR)為7.58%。心律不整病例的增加、技術的進步、對微創手術的需求不斷成長、醫療支出的增加、門診護理環境的擴大、優惠的報銷政策、早期診斷意識的提升以及人工智慧(AI)在醫療器械中的應用,都是推動市場成長的一些因素。
心律不整盛行率上升
心房顫動 (AF) 等心律不整以及其他各種惡性疾病的盛行率不斷上升,推動著市場的成長。根據行業報告,心房顫動 (AF),即心臟的電訊號/顫動問題,在美國影響近 270 萬人。 AF 是中風和心臟衰竭的最常見原因,給醫療服務帶來了越來越重的負擔。此外,技術進步和可支配收入的不斷成長也提高了患者對心律不整的認知,因此他們更傾向於早期診斷和治療。
電生理設備的技術進步
電生理設備市場的成長主要得益於科技的快速進步。 3D映射系統和其他創新技術使心臟科醫師能夠設計特定的心臟電活動模型,從而改善心律不整患者的診斷和治療。此外,導管消融技術的改進有助於降低手術風險,同時最大限度地縮短患者的康復時間並提高成功率。同時,機器人輔助系統在電生理學中的應用也提高了手術的精確度和控制力,這為市場成長提供了顯著的推動力。
微創手術的成長
微創 (MI) 電生理手術可以縮短恢復時間、縮短住院時間並降低手術風險,因此其在患者治療中的需求量龐大。用於治療心律不整的導管消融術等手術,比標準手術創傷更小。這進一步提高了診斷的準確性,並改善了治療效果,同時降低了手術成本並減輕了患者的負擔。此外,影像和測繪技術的發展也使 MI 介入更加簡便,從而促進了市場的成長。
診斷設備佔大部分市場佔有率
診斷設備細分市場的成長動力源自於心血管疾病(尤其是心律不整)日益成長的盛行率,這些疾病需要精確診斷才能有效治療。諸如改進的心電圖 (ECG) 和 EP 映射系統等技術進步正在提高診斷準確性,從而推動這些設備的廣泛應用。此外,人們對早期發現和預防心臟疾病的認知不斷提高,也推動了對動態心電圖 (Holter) 和植入式心臟監視器 (ICM) 等診斷工具的需求。醫療保健提供者越來越依賴這些設備進行持續監測和精準資料收集,從而改善患者的預後。微創診斷程序的興起,可以縮短患者恢復時間並減少住院時間,進一步促進了該細分市場的成長。
心房顫動(AF)佔據業界最大佔有率
心房顫動 (AF) 細分市場的發展受到全球 AF 盛行率不斷上升的推動,尤其是在老年人口中,AF 是導致中風和心臟衰竭的主要原因。隨著人們對 AF 的認知不斷加深,對早期診斷和有效治療的需求也日益成長,這促使醫療保健提供者投資先進的電生理設備。 3D 映射系統和導管消融技術等診斷工具的技術進步提高了 AF 檢測的準確性和治療成功率,從而促進了 AF 的普及。此外,人們對微創手術的日益青睞,因為這種手術可以縮短恢復時間並減少併發症,這進一步加速了 AF 管理中對電生理設備的需求。
醫院是主要的細分市場
醫院細分市場的成長動力源自於心血管疾病(尤其是心律不整)日益成長的盛行率,這些疾病需要專門的電生理治療。醫院配備了先進的技術,例如3D映射和導管消融系統,使其能夠提供全面的心臟護理。微創手術的需求日益成長,這些手術通常在醫院環境中進行,進一步推動了醫院細分市場的發展。此外,醫院擁有能夠處理複雜電生理治療的熟練醫療專業人員,增強了患者在這些機構就診的信心。醫療保健支出的不斷成長,尤其是在已開發地區,使得醫院能夠投資尖端電生理設備,從而提升其診療能力。
北美引領市場,佔據最大的電生理設備市場佔有率
該報告還對所有主要區域市場進行了全面分析,包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告指出,北美是電生理設備最大的區域市場。
從電生理設備市場動態來看,北美區域市場受老齡化人口中心血管疾病(尤其是心房顫動)盛行率上升的驅動。先進的醫療基礎設施和尖端醫療技術的廣泛普及,支持了該地區電生理設備的普及。人們對心臟病早期診斷和治療的認知不斷提高,也推動了對這些設備的需求。此外,人們對微創手術的日益青睞,也增加了導管消融術和其他電生理工具的使用。醫療技術的不斷進步,例如3D映射系統和人工智慧(AI)整合,提高了手術的準確性和療效,使其對患者和醫療保健提供者都更具吸引力,從而進一步推動了電生理設備的需求。
(請注意,這只是關鍵參與者的部分列表,完整列表在報告中提供。)
The global electrophysiology devices market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.9 Billion by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033. Rising cardiac arrhythmia cases, technological advancements, growing demand for minimally invasive procedures, increasing healthcare expenditure, expanding outpatient care settings, favorable reimbursement policies, escalating awareness of early diagnosis, and the integration of artificial intelligence (AI) in medical devices are some of the factors driving the market growth.
Rising Prevalence of Cardiac Arrhythmias
Increasing prevalence of cardiac arrhythmias such as atrial fibrillation (AF) and various other malignant are driving the market growth. According to the industry reports, atrial fibrillation (AF), known as the electrical or signaling/flutter problem in the heart, is affecting almost 2.7 million people in United States. AF is the most common cause of strokes and heart failure, which is creating a growing burden on health services. In addition, expanding technological advancements and disposable income has boosted awareness about arrhythmias among patients, due to which they prefer early diagnosis and treatment.
Technological Advancements in Electrophysiology Devices
The growth of the electrophysiology devices market is primarily bolstered by the rapid technological advancements. 3D mapping systems and other innovations enable cardiologists to design specified models of the heart's electrical activity, which improves diagnosis and treatment for patients suffering with arrhythmias. Additionally, the improvements in catheter ablation technologies helps reduce procedural risks, while minimizing patient recovery times and increasing success rates. In line with this, the use of robotic-assisted systems in electrophysiology has also improved the precision and control during procedures, which is providing a considerable boost to the market growth.
Growth of Minimally Invasive Procedures
Minimally invasive (MI) electrophysiology procedures can reduce recovery times, hospital stays, and procedural risks, which is why they are witnessing a considerable demand for the treatment of patients. Procedures such as catheter ablation, which are used to treat arrhythmias, provide a less traumatic alternative to the standard surgeries. This further enables an accurate diagnosis and enhances the results of treatment at a reduced cost and strain of surgeries on patients. Apart from this, the development of imaging and mapping technologies, in turn, has made MI interventions less cumbersome, which is facilitating the market growth.
Diagnostic devices accounts for the majority of the market share
The diagnostic devices segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require precise diagnosis for effective treatment. Technological advancements, such as improved electrocardiographs (ECGs) and EP mapping systems, are enhancing diagnostic accuracy, leading to wider adoption of these devices. Additionally, the growing awareness of early detection and prevention of heart conditions is boosting demand for diagnostic tools like Holter monitors and insertable cardiac monitors (ICMs). Healthcare providers are increasingly relying on these devices for continuous monitoring and accurate data collection, which improves patient outcomes. The rise in minimally invasive diagnostic procedures, which offer quicker recovery times and reduce the need for hospital stays, is further contributing to the segment's growth.
Atrial fibrillation (AF) holds the largest share of the industry
The atrial fibrillation (AF) segment is driven by the increasing global prevalence of AF, particularly among aging populations, which is a leading cause of stroke and heart failure. As awareness about AF grows, there is a rising demand for early diagnosis and effective treatment, prompting healthcare providers to invest in advanced electrophysiology devices. Technological advancements in diagnostic tools, such as 3D mapping systems and catheter ablation technologies, have improved the accuracy of AF detection and treatment success rates, boosting adoption. Additionally, the growing preference for minimally invasive procedures, which offer faster recovery times and reduced complications, is further accelerating demand for electrophysiology devices in AF management.
Hospitals represents the leading market segment
The hospital segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require specialized electrophysiology procedures. Hospitals are equipped with advanced technology, such as 3D mapping and catheter ablation systems, enabling them to offer comprehensive cardiac care. The growing demand for minimally invasive procedures, which are often performed in hospital settings, further fuels this segment. Additionally, hospitals have skilled healthcare professionals capable of handling complex electrophysiology treatments, which boosts patient confidence in seeking care at these facilities. Rising healthcare expenditure, particularly in developed regions, allows hospitals to invest in cutting-edge electrophysiology devices, enhancing their capabilities.
North America leads the market, accounting for the largest electrophysiology devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for electrophysiology devices.
As per the electrophysiology devices market dynamics, the North America's regional market is driven by the increasing prevalence of cardiovascular diseases, particularly atrial fibrillation, among the aging population. Advanced healthcare infrastructure and widespread access to cutting-edge medical technologies support the adoption of electrophysiology devices across the region. Rising awareness of early diagnosis and treatment of heart conditions is boosting demand for these devices. Additionally, the growing preference for minimally invasive procedures has increased the use of catheter ablation and other electrophysiology tools. Continuous advancements in medical technology, such as 3D mapping systems and artificial intelligence (AI) integration, enhance the accuracy and outcomes of procedures, making them more attractive to both patients and healthcare providers, which is further driving the electrophysiology devices demand.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)